Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Reports 7 Percent Increase in Preliminary Q1 Revenues

NEW YORK (GenomeWeb) – Hologic said today that it expects to report total revenues of $653 million for its fiscal first quarter ending Dec. 31, 2014.

The preliminary revenues represent a 7 percent increase over the prior-year period and exceed the company's previous quarterly revenue guidance of $625 million to $635 million. The projected revenues also beat consensus analyst estimates of $631 million for the quarter.

Hologic estimated a 6 percent increase in revenues for its Diagnostics business segment in the quarter, to $304 million. It projected $242 million in revenue for its Breast Health segment, which would be a 7 percent increase over the comparable period in 2013; $84 million in GYN Surgical revenue, also a 7 percent bump; and $22 million in Skeletal Health revenue, a 5 percent increase.   

Hologic also said today that it voluntarily prepaid $300 million of principal on a Term Loan B facility in December.

The company will release its full financial results for its first fiscal quarter on Jan. 28. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.